首页> 外文期刊>Metabolic engineering >Metabolic engineering of Escherichia coli for production of fatty acid short-chain esters through combination of the fatty acid and 2-keto acid pathways
【24h】

Metabolic engineering of Escherichia coli for production of fatty acid short-chain esters through combination of the fatty acid and 2-keto acid pathways

机译:大肠埃希氏菌的代谢工程,通过脂肪酸和2-酮酸途径的结合来生产脂肪酸短链酯

获取原文
获取原文并翻译 | 示例
       

摘要

Fatty acid short-chain esters (FASEs) are biodiesels that are renewable, nontoxic, and biodegradable biofuels. A novel approach for the biosynthesis of FASEs has been developed using metabolically-engineered E. coli through combination of the fatty acid and 2-keto acid pathways. Several genetic engineering strategies were also developed to increase fatty acyl-CoA availability to improve FASEs production. Fed-batch cultivation of the engineered £ coli resulted in a titer of 1008 mg/L FASEs. Since the fatty acid and 2-keto acid pathways are native microbial synthesis pathways, this strategy can be implemented in a variety of microorganisms to produce various FASEs from cheap and readily-available, renewable, raw materials such as sugars and cellulose in the future.
机译:脂肪酸短链酯(FASE)是可再生,无毒且可生物降解的生物燃料的生物柴油。通过代谢工程化的大肠杆菌,通过脂肪酸和2-酮酸途径的组合,已经开发出一种新型的FASE生物合成方法。还开发了几种基因工程策略来增加脂肪酰基辅酶A的利用率,以提高FASE的产量。分批培养工程化大肠杆菌的滴度为1008 mg / L FASE。由于脂肪酸和2-酮酸途径是天然的微生物合成途径,因此该策略可以在多种微生物中实施,以在未来从廉价且容易获得的可再生原材料(如糖和纤维素)中生产各种FASE。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号